Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Sigilon Therapeutics stock in Canada
Own Sigilon Therapeutics shares in just a few minutes.
Sigilon Therapeutics, Inc is a biotechnology business based in the US. Sigilon Therapeutics shares (SGTX.US) are listed on the NASDAQ and all prices are listed in US Dollars. Sigilon Therapeutics employs 99 staff and has a trailing 12-month revenue of around $13.4 million.
How to buy shares in Sigilon Therapeutics
- Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: SGTX in this case.
- Research Sigilon Therapeutics shares. The platform should provide the latest information available.
- Buy your Sigilon Therapeutics shares. It's that simple.
What's in this guide?
Sigilon Therapeutics share priceUse our graph to track the performance of SGTX stocks over time.
Sigilon Therapeutics shares at a glance
|Latest market close||$N/A|
|52-week range||$16.55 - $54.317|
|50-day moving average||$22.8106|
|200-day moving average||$30.1841|
|Wall St. target price||$50.25|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||N/A|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Sigilon Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Sigilon Therapeutics financials
|Revenue TTM||USD$13.4 million|
|Gross profit TTM||USD$-40,114,000|
|Return on assets TTM||-20.86%|
|Return on equity TTM||-68.72%|
|Market capitalisation||USD$569.7 million|
TTM: trailing 12 months
How to short and sell Sigilon Therapeutics shares
- Create a CFD or spread betting account.
- Search for the stock code. E.g. "SGTX.US"
- Choose your position size.
- Select "sell" rather than "buy".
- Confirm your position and keep tabs on it. You may wish to set limits on your position.
There are currently 571,027 Sigilon Therapeutics shares held short by investors – that's known as Sigilon Therapeutics's "short interest". This figure is 176.9% up from 206,247 last month.
There are a few different ways that this level of interest in shorting Sigilon Therapeutics shares can be evaluated.
Sigilon Therapeutics's "short interest ratio" (SIR)
Sigilon Therapeutics's "short interest ratio" (SIR) is the quantity of Sigilon Therapeutics shares currently shorted divided by the average quantity of Sigilon Therapeutics shares traded daily (recently around 190342.33333333). Sigilon Therapeutics's SIR currently stands at 3. In other words for every 100,000 Sigilon Therapeutics shares traded daily on the market, roughly 3000 shares are currently held short.
However Sigilon Therapeutics's short interest can also be evaluated against the total number of Sigilon Therapeutics shares, or, against the total number of tradable Sigilon Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Sigilon Therapeutics's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Sigilon Therapeutics shares in existence, roughly 20 shares are currently held short) or 0.0343% of the tradable shares (for every 100,000 tradable Sigilon Therapeutics shares, roughly 34 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Sigilon Therapeutics.
Find out more about how you can short Sigilon Therapeutics stock.
Sigilon Therapeutics share dividends
We're not expecting Sigilon Therapeutics to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Sigilon Therapeutics overview
Sigilon Therapeutics, Inc., a biopharmaceutical company, develops functional cures for patients with chronic diseases. Its lead product candidate is SIG-001, which is in Phase I/II clinical trial to prevent bleeding episodes in patients with moderate-severe to severe Hemophilia A. The company is also developing SIG-005 to treat the non-neurological manifestations of the disease in patients with mucopolysaccharidosis type 1; SIG-007 to provide continuous and prolonged release of functional enzyme at levels sufficient to produce clinical benefits and alleviate progression of the downstream aspects of Fabry disease; and SIG-002 designed to replace islet cells for the treatment of type 1 diabetes. The company was formerly known as Sigilon, Inc. and changed its name to Sigilon Therapeutics, Inc. in June 2017. Sigilon Therapeutics, Inc. was founded in 2015 and is headquartered in Cambridge, Massachusetts.
Frequently asked questions
More on investing
Companies are going public via direct listings and IPOs. Which should you invest in?Read more…
Biden’s plan to replace the federal fleet with American-made electric vehicles gives another boost to a red-hot sector led by Tesla.Read more…
Cruise ship stocks are sailing through murky waters, but can they rise?Read more…
More guides on Finder
How to buy Sanofi stock in Canada | $45.8
Steps to owning and managing SNY, with 24-hour and historical pricing before you buy.
How to buy NorthWestern Corporation stock in Canada
Steps to owning and managing NorthWestern Corporation stocks, with 24-hour and historical pricing before you buy.
How to buy Noble Corporation stock in Canada
Steps to owning and managing Noble Corporation stocks, with 24-hour and historical pricing before you buy.
How to buy NMI stock in Canada
Steps to owning and managing NMI stocks, with 24-hour and historical pricing before you buy.
How to buy nLIGHT stock in Canada
Steps to owning and managing nLIGHT stocks, with 24-hour and historical pricing before you buy.
How to buy NIO stock in Canada | $46.81
Steps to owning and managing NIO stocks, with 24-hour and historical pricing before you buy.
How to buy Nielsen stock in Canada
Steps to owning and managing Nielsen stocks, with 24-hour and historical pricing before you buy.
How to buy Newtek Business Services stock in Canada
Steps to owning and managing Newtek Business Services stocks, with 24-hour and historical pricing before you buy.
How to buy New Fortress Energy stock in Canada
Steps to owning and managing New Fortress Energy stocks, with 24-hour and historical pricing before you buy.
How to buy NeoGenomics stock in Canada
Steps to owning and managing NeoGenomics stocks, with 24-hour and historical pricing before you buy.